Serum-free Media Market Trends, Analysis & Forecast - 2032 

Serum-free Media Market Size - By Type (CHO Cell Culture, Protein Expression Media), Application (Biopharmaceutical Production, Stem Cell Research & Therapy), End-user & Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Serum-free media industry 360&ordm; synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Type trends

2.1.4&nbsp;&nbsp;&nbsp; Application trends

2.1.5&nbsp;&nbsp;&nbsp; End-user trends

Chapter 3&nbsp;&nbsp;&nbsp;Serum-free Media Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing adoption of cell culture technologies for cell-based vaccines

3.2.1.2&nbsp;&nbsp;&nbsp;Rising prevalence of infectious and chronic diseases

3.2.1.3&nbsp;&nbsp;&nbsp;Rising R&amp;D investments to develop novel regenerative therapies and disease specific solutions

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory guidelines

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By type

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By end-user

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Serum-free Media Market, By Type, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; CHO cell culture

5.3&nbsp;&nbsp;&nbsp; Protein expression media

5.4&nbsp;&nbsp;&nbsp; Stem cell media

5.5&nbsp;&nbsp;&nbsp; Immunology media

5.6&nbsp;&nbsp;&nbsp; Hybridoma media

5.7&nbsp;&nbsp;&nbsp; Other media types

Chapter 6&nbsp;&nbsp;&nbsp;Serum-free Media Market, By Application, 2018 - 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Biopharmaceutical production

6.3&nbsp;&nbsp;&nbsp; Tissue engineering &amp; regenerative medicine

6.4&nbsp;&nbsp;&nbsp; Stem cell research &amp; therapy

6.5&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Serum-free Media Market, By End-user, 2018 - 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-user

7.2&nbsp;&nbsp;&nbsp; Biopharmaceutical companies

7.3&nbsp;&nbsp;&nbsp; Clinical research organizations

7.4&nbsp;&nbsp;&nbsp; Academic research centers

Chapter 8&nbsp;&nbsp;&nbsp;Serum-free Media Market, By Region, 2018 - 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; Japan

8.4.2&nbsp;&nbsp;&nbsp; China

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; MEA

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Sartorius AG

9.2&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc.

9.3&nbsp;&nbsp;&nbsp; Merck KGaA

9.4&nbsp;&nbsp;&nbsp; FUJIFILM Irvine Scientific, Inc.

9.5&nbsp;&nbsp;&nbsp; Lonza Group

9.6&nbsp;&nbsp;&nbsp; MP Biomedicals

9.7&nbsp;&nbsp;&nbsp; Corning Incorporated

9.8&nbsp;&nbsp;&nbsp; PAN-Biotech

9.9&nbsp;&nbsp;&nbsp; R&amp;D Systems

9.10&nbsp;&nbsp;&nbsp; PromoCell GmbH 
&nbsp;

Serumfree Media Market

Get a free sample of this report